Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Covington
Farmers Insurance
Deloitte
Federal Trade Commission
Daiichi Sankyo
Cantor Fitzgerald
Cipla
Fish and Richardson

Generated: February 22, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

« Back to Dashboard

Clinical Trials for Morphine Sulfate; Naltrexone Hydrochloride

Trial ID Title Status Sponsor Phase Summary
NCT00415597 Study of Embeda (Kadian NT, ALO-01) in Subjects With Chronic Moderate to Severe Nonmalignant Pain Completed Pfizer Phase 3 Open-Label, Safety Study to evaluate the long-term safety of Kadian NT (ALO-01) administered for up to 12 months.
NCT00420992 A Study of Embeda (Kadian NT, ALO-01) in Subjects With Pain Due to Osteoarthritis of the Hip or Knee Completed Pfizer Phase 3 The purpose of this study is to evaluate the efficacy of Kadian NT (ALO-01) compared with placebo for treating moderate to severe chronic pain over a 12 week period.
NCT01179191 Conversion to Embeda With Rescue Trial Terminated Pfizer Phase 4 The purpose of the research study is to find out if opioid dependent chronic pain patients who are judged by their physician to be eligible to change their current opioid medicine and to participate in this study can be successfully adjusted to a stable dose of EMBEDA (morphine sulfate and naltrexone hydrochloride). The study will also assess each patient's risk for prescription opioid abuse, misuse and diversion.
NCT01665209 Bioequivalence Study of Morphine Sulfate 60 mg Extended-Release Tablets Under Fed Conditions Completed Ranbaxy Inc. Phase 1 The study was to evaluate the relative bioavailability of morphine and morphine-6-glucuronide from 2 tablet products and determine if the 2 products were bioequivalent to each other.
NCT01665222 Bioequivalence Study of Morphine Sulfate 60 mg Extended-Release Tablets Under Fasting Conditions Completed Ranbaxy Inc. Phase 1 The study was to evaluate the relative bioavailability of morphine and morphine-6-glucuronide from 2 tablet products and determine if the 2 products were bioequivalent to each other.
NCT02101554 Safety and Pharmacokinetic Study of EMBEDA in Children Ages 7-17 With Pain Recruiting Pfizer Phase 4 Safety and pharmacokinetics of an abuse-deterrent, extended-release formulation of morphine sulfate with a sequestered naltrexone core in children 7-17 with moderate-severe pain.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Morphine Sulfate; Naltrexone Hydrochloride

Condition Name

Condition Name for Morphine Sulfate; Naltrexone Hydrochloride
Intervention Trials
Healthy 2
Pain 2
Osteoarthritis 1
Moderate-severe Pain (All Types) 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Morphine Sulfate; Naltrexone Hydrochloride
Intervention Trials
Chronic Pain 1
Chronic Disease 1
Osteoarthritis, Hip 1
Osteoarthritis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Morphine Sulfate; Naltrexone Hydrochloride

Trials by Country

Trials by Country for Morphine Sulfate; Naltrexone Hydrochloride
Location Trials
United States 93
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Morphine Sulfate; Naltrexone Hydrochloride
Location Trials
Florida 4
California 4
North Carolina 3
Illinois 3
Indiana 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Morphine Sulfate; Naltrexone Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Morphine Sulfate; Naltrexone Hydrochloride
Clinical Trial Phase Trials
Phase 4 2
Phase 3 2
Phase 1 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Morphine Sulfate; Naltrexone Hydrochloride
Clinical Trial Phase Trials
Completed 4
Terminated 1
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Morphine Sulfate; Naltrexone Hydrochloride

Sponsor Name

Sponsor Name for Morphine Sulfate; Naltrexone Hydrochloride
Sponsor Trials
Pfizer 4
Ranbaxy Inc. 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Morphine Sulfate; Naltrexone Hydrochloride
Sponsor Trials
Industry 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Express Scripts
Moodys
Queensland Health
McKinsey
Deloitte
Chinese Patent Office
Farmers Insurance
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.